Key Points
- Insider sale: Director Gerry Keller sold 236 shares on Nov. 21 at an average price of $1,418.58 for a total of $334,784.88, reducing his stake to 159 shares (a 59.75% decrease), per an SEC Form 4 filing.
- Earnings beat and guidance: Mettler‑Toledo reported quarterly EPS of $11.15 (vs. $10.62 expected) and $1.03B in revenue, and issued Q4 2025 guidance of 12.680–12.880 EPS and FY2025 guidance of 42.050–42.250 EPS.
- Market and analyst snapshot: The stock trades around $1,506.58 with a $30.78B market cap and a 52‑week range of $946.69–$1,525.17; analysts have a consensus "Hold" rating with a $1,406.50 target and institutional investors own roughly 95% of the shares.
Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) insider Gerry Keller sold 236 shares of the business's stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $1,418.58, for a total value of $334,784.88. Following the completion of the transaction, the insider owned 159 shares in the company, valued at $225,554.22. This trade represents a 59.75% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Mettler-Toledo International Price Performance
Shares of Mettler-Toledo International stock opened at $1,506.58 on Wednesday. The firm has a market cap of $30.78 billion, a price-to-earnings ratio of 38.15, a P/E/G ratio of 4.19 and a beta of 1.41. The stock has a 50-day simple moving average of $1,356.38 and a 200-day simple moving average of $1,268.12. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International's quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Institutional Trading of Mettler-Toledo International
Several large investors have recently made changes to their positions in MTD. Bank of New York Mellon Corp raised its position in shares of Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock worth $1,062,257,000 after acquiring an additional 376,419 shares during the last quarter. Norges Bank bought a new position in Mettler-Toledo International in the second quarter valued at about $360,126,000. Alliancebernstein L.P. raised its holdings in Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after purchasing an additional 126,147 shares during the last quarter. PineStone Asset Management Inc. raised its holdings in Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier's stock worth $392,766,000 after purchasing an additional 98,737 shares during the last quarter. Finally, Rakuten Investment Management Inc. bought a new position in shares of Mettler-Toledo International in the 3rd quarter valued at about $121,021,000. Institutional investors own 95.07% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on MTD. Weiss Ratings reiterated a "hold (c)" rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. JPMorgan Chase & Co. lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a "neutral" rating in a research note on Thursday, October 9th. Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an "equal weight" rating in a research note on Monday, November 10th. Robert W. Baird lifted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Finally, Stifel Nicolaus raised their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a "buy" rating in a research report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $1,406.50.
Read Our Latest Stock Analysis on MTD
Mettler-Toledo International Company Profile
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
